A study of the dexamethasone sodium phosphate release properties from a periocular capsular drug delivery system

References

• Ambati J, Adamis AP. (2002). Transscleral drug delivery to the retina and choroid. Prog Retin Eye Res 2:145–51
   Web of Science ®Google Scholar
• Ambati J, Canakis CS, Miller JW, et al. (2000). Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci 5:1181–5
   Google Scholar
• Bakri SJ, Omar AF. (2012). Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (Ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion. J Ocul Pharmacol Ther 5:547–9
   Web of Science ®Google Scholar
• Bali E, Feron EJ, Peperkamp E, et al. (2010). The effect of a preoperative subconjuntival injection of dexamethasone on blood-retinal barrier breakdown following scleral buckling retinal detachment surgery: a prospective randomized placebo-controlled double blind clinical trial. Graefes Arch Clin Exp Ophthalmol 7:957–62
   Web of Science ®Google Scholar
• Bansal R, Bansal P, Kulkarni P, et al. (2012). Wandering Ozurdex® implant. J Ophthalmic Inflamm Infect 1:1–5
   Google Scholar
• Bill A, Tornquist P, Alm A. (1980). Permeability of the intraocular blood vessels. Trans Ophthalmol Soc U K 3:332–6
   Google Scholar
• Bodker FS, Ticho BH, Feist RM, Lam TT. (1993). Intraocular dexamethasone penetration via subconjunctival or retrobulbar injections in rabbits. Ophthalmic Surg 7:453–7
   Google Scholar
• Candiello J, Cole GJ, Halfter W. (2010). Age-dependent changes in the structure, composition and biophysical properties of a human basement membrane. Matrix Biol 5:402–10
   Web of Science ®Google Scholar
• Chang-Lin JE, Attar M, Acheampong AA, et al. (2011). Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci 1:80–6
   Web of Science ®Google Scholar
• Chen X, Liu Y, Jiang Z, et al. (2011). Protein kinase C alpha downregulation via siRNA-PKC alpha released from foldable capsular vitreous body in cultured human retinal pigment epithelium cells. Int J Nanomedicine 6:1303–11
   PubMed Web of Science ®Google Scholar
• Cheruvu NP, Kompella UB. (2006). Bovine and porcine transscleral solute transport: influence of lipophilicity and the Choroid-Bruch's layer. Invest Ophthalmol Vis Sci 10:4513–22
   Web of Science ®Google Scholar
• Clemens CR, Bertelmann T, Meyer CH. (2013). Vitreous traction after Ozurdex injection. J Ocul Pharmacol Ther 1:3–4
   Web of Science ®Google Scholar
• Congdon N, O'colmain B, Klaver CC, et al. (2004). Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 4:477–85
   Google Scholar
• Dalkara D, Kolstad KD, Caporale N, et al. (2009). Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous. Mol Ther 12:2096–102
   Web of Science ®Google Scholar
• Dieleman M, Wubbels RJ, Van Kooten-Noordzij M, De Waard PW. (2011). Single perioperative subconjunctival steroid depot versus postoperative steroid eyedrops to prevent intraocular inflammation and macular edema after cataract surgery. J Cataract Refract Surg 9:1589–97
   Web of Science ®Google Scholar
• Durrani OM, Meads CA, Murray PI. (2004). Uveitis: a potentially blinding disease. Ophthalmologica 4:223–36
   Web of Science ®Google Scholar
• Edelhauser HF, Rowe-Rendleman CL, Robinson MR, et al. (2010). Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. Invest Ophthalmol Vis Sci 11:5403–20
   Web of Science ®Google Scholar
• Geroski DH, Edelhauser HF. (2001). Transscleral drug delivery for posterior segment disease. Adv Drug Deliv Rev 1:37–48
   Web of Science ®Google Scholar
• Hughes PM, Olejnik O, Chang-Lin JE, Wilson CG. (2005). Topical and systemic drug delivery to the posterior segments. Adv Drug Deliv Rev 14:2010–32
   Web of Science ®Google Scholar
• Jackson GR, Barber AJ. (2010). Visual dysfunction associated with diabetic retinopathy. Curr Diab Rep 5:380–4
   Web of Science ®Google Scholar
• Jager RD, Aiello LP, Patel SC, Cunningham ET Jr. (2004). Risks of intravitreous injection: a comprehensive review. Retina 5:676–98
   Web of Science ®Google Scholar
• James ER. (2007). The etiology of steroid cataract. J Ocul Pharmacol Ther 5:403–20
   Web of Science ®Google Scholar
• Jiang Z, Wang T, Pan B, et al. (2012). Evaluation of the levofloxacin release characters from a rabbit foldable capsular vitreous body. Int J Nanomedicine 7:1–10
   PubMed Web of Science ®Google Scholar
• Kim SH, Lutz RJ, Wang NS, Robinson MR. (2007). Transport barriers in transscleral drug delivery for retinal diseases. Ophthalmic Res 5:244–54
   Web of Science ®Google Scholar
• Kuppermann BD, Loewenstein A. (2010). Drug delivery to the posterior segment of the eye. Dev Ophthalmol 47:59–72
   PubMedGoogle Scholar
• Lee SJ, Kim ES, Geroski DH, et al. (2008). Pharmacokinetics of intraocular drug delivery of Oregon green 488-labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyes. Invest Ophthalmol Vis Sci 10:4506–14
   Web of Science ®Google Scholar
• Lin X, Ge J, Gao Q, et al. (2011). Evaluation of the flexibility, efficacy, and safety of a foldable capsular vitreous body in the treatment of severe retinal detachment. Invest Ophthalmol Vis Sci 1:374–81
   Web of Science ®Google Scholar
• Liu Y, Ke Q, Chen J, et al. (2010). Sustained mechanical release of dexamethasone sodium phosphate from a foldable capsular vitreous body. Invest Ophthalmol Vis Sci 3:1636–42
   Web of Science ®Google Scholar
• Manandhar A. (2011). Seasonal hyperacute panuveitis: an update. Curr Opin Ophthalmol 6:496–501
   Web of Science ®Google Scholar
• Olsen TW, Edelhauser HF, Lim JI, Geroski DH. (1995). Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning. Invest Ophthalmol Vis Sci 9:1893–903
   Google Scholar
• Pitkanen L, Ranta VP, Moilanen H, Urtti A. (2005). Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity. Invest Ophthalmol Vis Sci 2:641–6
   Web of Science ®Google Scholar
• Pontes De Carvalho RA, Krausse ML, Murphree AL, et al. (2006). Delivery from episcleral exoplants. Invest Ophthalmol Vis Sci 10:4532–9
   Web of Science ®Google Scholar
• Prausnitz MR, Noonan JS. (1998). Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci 12:1479–88
   Web of Science ®Google Scholar
• Robinson MR, Lee SS, Kim H, et al. (2006). A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide. Exp Eye Res 3:479–87
   Web of Science ®Google Scholar
• Rohdewald P, Mollmann H, Barth J, et al. (1987). Pharmacokinetics of dexamethasone and its phosphate ester. Biopharm Drug Dispos 3:205–12
   Web of Science ®Google Scholar
• Shah SS, Denham LV, Elison JR, et al. (2010). Drug delivery to the posterior segment of the eye for pharmacologic therapy. Expert Rev Ophthalmol 1:75–93
   Google Scholar
• Thakur A, Kadam RS, Kompella UB. (2011). Influence of drug solubility and lipophilicity on transscleral retinal delivery of six corticosteroids. Drug Metab Dispos 5:771–81
   Web of Science ®Google Scholar
• Thrimawithana TR, Young S, Bunt CR, et al. (2011). Drug delivery to the posterior segment of the eye. Drug Discov Today 5–6:270–7
   Web of Science ®Google Scholar
• Wang P, Gao Q, Jiang Z, et al. (2012). Biocompatibility and retinal support of a foldable capsular vitreous body injected with saline or silicone oil implanted in rabbit eyes. Clin Experiment Ophthalmol 1:e67–75
   Web of Science ®Google Scholar
• Weijtens O, Feron EJ, Schoemaker RC, et al. (1999). High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection. Am J Ophthalmol 2:192–7
   Web of Science ®Google Scholar
• Weijtens O, Van Der Sluijs FA, Schoemaker RC, et al. (1997). Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection. Am J Ophthalmol 3:358–63
   Web of Science ®Google Scholar
• Zheng H, Wang Z, Wang P, et al. (2012). Evaluation of 5-fluorouracil released from a foldable capsular vitreous body in vitro and in vivo. Graefes Arch Clin Exp Ophthalmol 5:751–9
   Web of Science ®Google Scholar